We are live on ! Find out more
SCP

Stamos Capital Partners Portfolio holdings

AUM $640M
1-Year Est. Return 15.65%
This Fund
S&P 500
This Quarter Est. Return
+2.73%
1 Year Est. Return
+15.65%
3 Year Est. Return
+28.4%
5 Year Est. Return
+40.05%
10 Year Est. Return
AUM
$622M
AUM Growth
+$92.2M
Cap. Flow
+$76.5M
Cap. Flow %
12.29%
Top 10 Hldgs %
35.52%
Holding
144
New
2
Increased
94
Reduced
40
Closed
8

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$5.49M
2
PG icon
Procter & Gamble
PG
+$3.73M
3
CVX icon
Chevron
CVX
+$3.33M
4
T icon
AT&T
T
+$3.04M
5
NFLX icon
Netflix
NFLX
+$3.03M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$2.7M
2
SLB icon
SLB Ltd
SLB
+$2.36M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.36M
4
TTE icon
TotalEnergies
TTE
+$1.77M
5
NEE icon
NextEra Energy
NEE
+$1.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.59%
2 Energy 12.9%
3 Technology 12.01%
4 Financials 10.21%
5 Communication Services 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNI icon
26
Canadian National Railway
CNI
$76.5B
$5.95M 0.96%
60,220
+24,418
+68% +$2.35M
BA icon
27
Boeing
BA
$184B
$5.94M 0.96%
27,378
+1,306
+5% +$269K
GSK icon
28
GSK
GSK
$104B
$5.89M 0.95%
120,183
-17,051
-12% -$795K
CP icon
29
Canadian Pacific Kansas City
CP
$79.3B
$5.69M 0.91%
77,291
+34,646
+81% +$2.55M
VZ icon
30
Verizon
VZ
$195B
$5.5M 0.88%
135,065
+48,429
+56% +$1.96M
CI icon
31
Cigna
CI
$72.7B
$5.39M 0.87%
+19,597
New +$5.49M
CVS icon
32
CVS Health
CVS
$123B
$5.38M 0.87%
67,848
+29,233
+76% +$2.3M
BLK icon
33
Blackrock
BLK
$175B
$5.28M 0.85%
4,935
+1,011
+26% +$1.11M
CRM icon
34
Salesforce
CRM
$153B
$5.23M 0.84%
19,734
+1,527
+8% +$379K
ADBE icon
35
Adobe
ADBE
$103B
$5.2M 0.84%
14,860
+2,018
+16% +$686K
LLY icon
36
Eli Lilly
LLY
$1.06T
$5.13M 0.83%
4,778
-1,424
-23% -$1.36M
PG icon
37
Procter & Gamble
PG
$342B
$4.8M 0.77%
33,484
+25,316
+310% +$3.73M
ASML icon
38
ASML
ASML
$655B
$4.79M 0.77%
4,475
-2,586
-37% -$2.7M
CME icon
39
CME Group
CME
$95B
$4.76M 0.77%
17,447
+6,727
+63% +$1.83M
ENB icon
40
Enbridge
ENB
$113B
$4.6M 0.74%
96,213
+43,389
+82% +$2.07M
MDT icon
41
Medtronic
MDT
$110B
$4.58M 0.74%
47,719
+5,027
+12% +$488K
PAVE icon
42
Global X US Infrastructure Development ETF
PAVE
$15.1B
$4.44M 0.71%
93,008
+56,649
+156% +$2.72M
KO icon
43
Coca-Cola
KO
$374B
$4.25M 0.68%
60,849
+41,934
+222% +$2.92M
F icon
44
Ford
F
$55B
$4.18M 0.67%
318,383
-62,563
-16% -$807K
KMI icon
45
Kinder Morgan
KMI
$69.7B
$4.13M 0.66%
150,299
+86,245
+135% +$2.33M
BRK.B icon
46
Berkshire Hathaway Class B
BRK.B
$1.13T
$3.94M 0.63%
7,834
+3,509
+81% +$1.75M
NFLX icon
47
Netflix
NFLX
$307B
$3.87M 0.62%
41,327
+28,097
+212% +$3.03M
BX icon
48
Blackstone
BX
$107B
$3.73M 0.6%
24,204
+6,028
+33% +$916K
BN icon
49
Brookfield
BN
$108B
$3.66M 0.59%
79,832
-5,740
-7% -$262K
AMLP icon
50
Alerian MLP ETF
AMLP
$12.9B
$3.55M 0.57%
75,427
+24,714
+49% +$1.16M

Similar funds

Stamos Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Stamos Capital Partners held 144 positions worth $622M, up 17% from $530M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Stamos Capital Partners deployed $76.5M of net new capital in Q4 2025, opening 2 new positions and adding to 94 existing holdings. Its largest new stake was Cigna: 19,597 shares worth $5.39M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was ASML, an estimated $2.7M trimmed.

  • Stamos Capital Partners's largest Q4 2025 buy was Cigna: 19,597 shares worth $5.39M.
  • Stamos Capital Partners added most to Procter & Gamble in Q4 2025, an estimated $3.73M increase.
  • Stamos Capital Partners's biggest Q4 2025 reduction was ASML, cutting an estimated $2.7M.
  • Stamos Capital Partners fully exited Brookfield Asset Management in Q4 2025, selling an estimated $281K.
  • Stamos Capital Partners's ten largest holdings make up 36% of its $622M portfolio in Q4 2025.
  • Stamos Capital Partners opened 2 new positions and closed 8 in Q4 2025.
  • Stamos Capital Partners's portfolio value rose 17% quarter-over-quarter to $622M.

Based on Stamos Capital Partners's 13F filing for Q4 2025, filed 12 Feb 2026.